Table 5.
Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|
Risk factors | LLNM+ | LLNM− | P value | P value | OR (95% CI) |
Age at diagnosis (years) | 0.134 | ||||
<55 | 93 | 723 | |||
≥55 | 24 | 267 | |||
Gender | 0.429 | ||||
Female | 84 | 744 | |||
Male | 33 | 246 | |||
Tumor size (mm) | <0.001 | ||||
≤5 | 15 | 369 | <0.001 | ||
>5, ≤10 | 21 | 345 | <0.002 | 13.165 (6.177–28.060) | |
>10, ≤20 | 51 | 243 | <0.003 | 11.946 (5.909–24.151) | |
>20 | 30 | 33 | <0.004 | 4.917 (2.614–9.250) | |
Multifocal neoplasms | 0.958 | ||||
Positive | 24 | 201 | |||
Negative | 93 | 789 | |||
Bilateral neoplasms | 0.109 | ||||
Positive | 24 | 147 | |||
Negative | 93 | 843 | |||
Extrathyroidal extension | 0.006 | 0.445 | |||
Positive | 21 | 96 | |||
Negative | 96 | 894 | |||
Hashimoto thyroiditis | 0.503 | ||||
Positive | 18 | 177 | |||
Negative | 99 | 813 | |||
CLNM | <0.001 | <0.001 | 5.463 (3.264–9.143) | ||
Positive | 96 | 357 | |||
Negative | 21 | 633 |
CLNM: central lymph node metastasis; LLNM: lateral lymph node metastasis.